Hypovitaminosis D is common in both urban and rural Indians. The dose of vitamin D needed for the treatment of its deficiency during pregnancy is not clear. We conducted a study in rural Indians to evaluate the effect of cholecalciferol supplementation during routine antenatal visits on maternal 25 hydroxyvitamin D (25OHD) at delivery. Pregnant women received either no cholecalciferol (Group A) or 60 000 U (Group B) in the fifth month of gestation or 120 000 U each in the fifth and seventh gestational months (Group C). Serum 25OHD was measured at baseline (n ¼ 139) and at delivery (n ¼ 84). Median (interquartile range) 25OHD
Introduction
Vitamin D deficiency is highly prevalent in urban and rural India (Balasubramanian et al., 2003; Sahu et al., 2009) , and pregnant women and newborns are vulnerable groups (Sachan et al., 2005; Balasubramanian et al., 2006) . Data regarding appropriate doses of vitamin D during pregnancy are scant (Brooke et al., 1980; Marya et al., 1988; Madelenat et al., 2001; Datta et al., 2002 ). An exhaustive review of the topic (Hollis and Wagner, 2004) concluded that current national recommendations for vitamin D supplementation doses in pregnancy are grossly inadequate. Furthermore, no study on the efficacy of education with regard to the benefits of sun exposure has been conducted in India. We evaluated the effect of two dose regimens of cholecalciferol in pregnant women, compared with education about sun exposure, on maternal serum 25 hydroxyvitamin D (25OHD) at delivery.
Participants and methods
Consecutive pregnant women (n ¼ 150) pregnant women (n ¼ 150) from six villages of a poor socio-economic region in district Barabanki (latitude 26.81N, Uttar Pradesh, north India) were invited during their second trimester to participate in this study. Consent for investigations was available in 139 participants at initial contact and in 84 after delivery. Those who did not give consent at delivery owned significantly less land, had lower calcium intake and greater duration of sun exposure than those who gave consent (data not shown). Every woman was educated about the importance of sun exposure and advised to get 60 min of sun exposure daily, at least on the face, forearms and hands, and preferably on more areas. Each woman was provided with calcium carbonate in the dosage of 1 g elemental calcium per day, to be taken in two divided doses with meals, and ferrous sulfate as 60 mg elemental iron per day, to be had while fasting. The participants were initially randomized to receive either no dose (Group A) or one dose of 60 000 U cholecalciferol under observation (Group B) in the fifth gestational month. However, the first few results showed rampant vitamin D deficiency and no improvement at delivery despite good exposure to sun and calcium supplementation. The baseline median (interquartile range, IQR) serum 25OHD was 32.3 nmol/l (22.8-50.1 nmol/l); 103 of 139 women (74%) had 25OHD o50 nmol/l and 44 of 139 (32%) had 25OHD o25 nmol/l (reported in Sahu et al., 2009) . We therefore decided that it was unethical to continue with a group not receiving any cholecalciferol. Therefore, this randomization was abandoned subsequently and two comparison groups were followed up, alternate women receiving either 60 000 U in the fifth month or 120 000 U each in the fifth and seventh months of pregnancy (Group C). Written informed consent from all participants and ethics committee approval were obtained. A food frequency questionnaire was used for the calculation of dietary calcium intake. The duration of daily sun exposure between 1000 hours and 1600 hours was recorded for summer and winter. Serum 25OHD was measured by radioimmunoassay (Diasorin, Stillwater, OK, USA). Statistical analysis was carried out using SPSS software (version 10.0, Chicago, IL, USA). The KruskallWallis test was used for multiple groups, the Mann-Whitney U test for between-groups and the Wilcoxon signed ranked test for paired variables comparison. Repeated-measures ANOVA (analysis of variance) using a general linear model, with a 25OHD measurement at the two time points as the withinparticipant variable, and the treatment group as the betweenparticipant factor, was used to assess the difference in baseline and post-delivery 25OHD. Categorical variables were tested by Fischer's exact and w 2 -tests. A two tailed P-value o0.05 was considered significant.
Results
A total of 84 women consented for blood sampling after delivery, 14 in group A and 35 each in groups B and C (the equal number in final follow-up at delivery in groups B and C was purely by chance, resulting from the greater drop out rate in group B than in group C). All women had baseline calcium intake less than the daily recommended intake (median 163 mg/day, IQR 91-340 mg/day). The mean ± s.d. daily sun exposure between 1000 hours and 1600 hours was 2.6±1.2 h in summer and 4.1±1.2 h in winter. Area exposed included face, forearms and hands in summer, and face and hands in winter. At baseline, compared with other groups, group A had a significantly lower serum 25OHD (Table 1) , but similar daily calcium intake, age, parity and sun exposure (data not shown). Groups B and C did not differ from each other. Post-delivery 25OHD in group C, 53.4 (41.2-88.0 nmol/l), was significantly higher than that in groups A, 23.8 (17.2-32.6) nmol/l, and B, 30.9 (24.8-48.1) nmol/l, as was the increase from baseline (Table 1 ). The same trend was observed when only deliveries conducted in winter (December to February) were analyzed. A significant difference between baseline and post-delivery mean 25OHD between the three treatment groups was observed when tested by repeated measures ANOVA (P ¼ 0.004). In the within-participants analyses of each treatment group, a significant difference between baseline and post-delivery 25OHD was only seen in group C (P ¼ 0.001). However, even two doses of 120 000 U each did not raise the serum 25OHD to the desirable levels of 480 nmol/l in a significant proportion of participants (Table 1) . No participant had hypervitaminosis D (serum 25OHD 4375 nmol/l).
Discussion
In this pilot interventional trial with sun exposure education or oral cholecalciferol supplementation in pregnant women, we found that the women already spent more time in the sun than that which was prescribed by us, albeit with a small percentage of skin exposed. Our education did not result in any further behavioral change. It is well known that previtamin D formation in the dermis is efficient, and exposure to the summertime noon sun beyond approximately 15-30 min in fair races and for approximately 60-90 min in dark people will not result in further vitamin D formation Vitamin D replacement in pregnant Indian women M Sahu et al (Holick et al., 1981) . Therefore, the only way our women could have taken more advantage of the sunshine was to decrease the area of skin covered by clothing. However, this is not a practical approach, as clothing pattern is a part of tradition. Thus, it seems that pharmacological replacement might have to be resorted to in India for public health programs for vulnerable populations. We chose to give cholecalciferol doses to coincide with the routine antenatal visits of the community health worker in India. A single dose of 60 000 U given during the second trimester was unable to significantly increase the maternal 25OHD concentrations at delivery. In contrast, women who received two doses of 120 000 U each in the mid and third trimesters had a significant increase of serum 25OHD as compared with that at baseline. Though the comparatively greater impact of the larger dose was documented during the vulnerable winter period also, it must be highlighted that a desirable level of serum 25OHD (480 nmol/l) was achieved in only a third of women overall and a in fifth of women delivering in winter. A similar large-dose intervention study has been reported from France (Madelenat et al., 2001) . Participants given 80 000 IU of ergocalciferol between 27 and 32 weeks of gestation were prevented from developing 25OHD o25 nmol/l at delivery. Marya et al. administered two doses of 600 000 IU vitamin D in the third trimester to Indian women and found a significant improvement in birth weight and maternal and cord blood biochemical parameters. However, circulating 25OHD was not estimated in that study and a minimum effective dose had not been sought (Marya et al., 1988) . Recent supplementation studies have involved non-pregnant participants. Serum 25OHD was significantly increased by administration of 60 000 U of vitamin D2 per month for 3 months in lactating women (Saadi et al., 2007) . However, levels 450 nmol/l were achieved only in 30% participants. The authors did not provide information as to how many participants achieved a value of 480 nmol/l. Vitamin D3 in a single oral dose of 100 000 U given to adult men and women was safe and effective in raising 25OHD to 480 nmol/l in 93% of the participants (Ilahi et al., 2008) . Mean 25OHD stayed above 80 nmol/l for up to 70 days and approximately above 70 nmol/l for 90 days. However, the baseline 25OHD of these individuals, 67 nmol/l, was higher than that in our participants. Individuals with a low baseline level would be expected to show a more modest response.
Our study has a shortcoming in that the randomization of vitamin D supplementation groups started at the onset of the study could not be maintained throughout the study because of reasons explained above, and that alternate rather than random numbers were used to allocate women to groups B and C. Furthermore, we did not test the efficacy of 60 000 U given both in the fifth and seventh months, and hence cannot rule out a beneficial effect of this regimen. Larger randomized trials are needed to verify the efficacy and safety of various vitamin D doses in pregnancy.
In conclusion, we report that a supervised administration of 120 000 U of oral cholecalciferol during the fifth and seventh gestational months is shown to be moderately effective in raising circulating 25OHD at delivery. This schedule can be combined with the routine antenatal program followed in India.
